These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2144921)

  • 1. Low anticoagulant activity of high sulphated heparan sulphates.
    Kovensky J; Sassetti B; Fernández Cirelli A; Kordich L
    Thromb Haemost; 1990 Jun; 63(3):488-92. PubMed ID: 2144921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant properties in vitro of heparan sulphates.
    Hubbard AR; Jennings CA; Barrowcliffe TW
    Thromb Res; 1984 Sep; 35(5):567-76. PubMed ID: 6237461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen.
    Horner AA
    Biochem J; 1990 Mar; 266(2):553-9. PubMed ID: 2138457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of the heparan sulfate proteoglycans from the extracellular matrix of rat skeletal muscle.
    Brandan E; Inestrosa NC
    J Neurobiol; 1987 May; 18(3):271-82. PubMed ID: 2955079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates.
    Casu B; Johnson EA; Mantovani M; Mulloy B; Oreste P; Pescador R; Prino G; Torri G; Zoppetti G
    Arzneimittelforschung; 1983; 33(1):135-42. PubMed ID: 6219676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate proteoglycans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin.
    Vallen EA; Eldridge KA; Culp LA
    J Cell Physiol; 1988 May; 135(2):200-12. PubMed ID: 2967301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of N-sulphated disaccharide units in heparin-like polysaccharides.
    Jacobsson I; Höök M; Pettersson I; Lindahl U; Larm O; Wirén E; von Figura K
    Biochem J; 1979 Apr; 179(1):77-87. PubMed ID: 157737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between heparan sulphate chains. I. A gel chromatographic, light-scattering and structural study of aggregating and non-aggregating chains.
    Fransson LA; Nieduszynski LA; Sheehan JK
    Biochim Biophys Acta; 1980 Jun; 630(2):287-300. PubMed ID: 6446326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides.
    Gallagher JT; Walker A
    Biochem J; 1985 Sep; 230(3):665-74. PubMed ID: 2933029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
    Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies on heparan sulphates. Characterization of oligosaccharides; obtained by periodate oxidation and alkaline elimination.
    Fransson LA; Sjöberg I; Havsmark B
    Eur J Biochem; 1980 May; 106(1):59-69. PubMed ID: 6280999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of low molecular weight glycosaminoglycans from marine mollusc Amussium pleuronectus (linne) using chromatography.
    Saravanan R; Shanmugam A
    Appl Biochem Biotechnol; 2010 Mar; 160(3):791-9. PubMed ID: 19184547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
    Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
    J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium.
    Marcum JA; Rosenberg RD
    Semin Thromb Hemost; 1987 Oct; 13(4):464-74. PubMed ID: 2962288
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralisation of heparan sulphate and low molecular weight heparin by protamine.
    Hubbard AR; Jennings CA
    Thromb Haemost; 1985 Feb; 53(1):86-9. PubMed ID: 3158095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
    Hausser H; Kresse H
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate.
    Höök M; Lindahl U; Iverius PH
    Biochem J; 1974 Jan; 137(1):33-43. PubMed ID: 4206909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.